Stable β-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice

American Journal of Pathology

Volumn 160, Issue 2, 2002, Pages 731-738

  Gau, Jen Tzer ^a   Steinhilb, Michelle L ^a   Kao, Tzu Cheg ^e   D'Amato, Constance J ^a   Gaut, James R ^a,b   Frey, Kirk A ^a,c   Turner, R Scott ^a,b,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Uniformed Services University of the Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; BETA SECRETASE; CHOLINE ACETYLTRANSFERASE; VESICULAR ACETYLCHOLINE TRANSPORTER;

AGING; ALZHEIMER DISEASE; AMYLOID NEUROPATHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; MALE; MOUSE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0036169190     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64893-6     Document Type: Article

References (76)

1. Selective loss of central cholinergic neurons in Alzheimer's disease
2. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies
3. Necropsy evidence of central cholinergic deficits in senile dementia
4. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients
5. Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease, evidence from rapid autopsy studies
6. High affinity choline transporter status in Alzheimer's disease tissue from rapid autopsy
7. Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
8. Convergent cholinergic activities in aging and Alzheimer's disease
9. Morphology and distribution of Alzheimer neuritic (senile) and amyloid plaques in striatum and diencephalon
10. Human striatum: Chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease
11. Alzheimer disease and senile dementia: Loss of neurons in the basal forebrain
12. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase
13. Long-term neuropathologic and neurochemical effects of nucleus basalis lesions in the rat
14. Translating cell biology into therapeutic advances in Alzheimer's disease
15. Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: A positron emission tomography study
16. The cholinergic deficit coincides with Aβ deposition at the earliest histopathologic stages of Alzheimer disease
17. Cholinergic markers in elderly patients with early signs of Alzheimer disease
18. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease J Comp Neurol
19. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
20. Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein London mutant transgenic mice
21. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes
22. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice
23. AppSw transgenic mice develop age-related Abeta deposits and neuropil abnormalities, but no neuronal loss in CA1
24. sw transgenic mice
25. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
26. Transgenic mice expressing Alzheimer amyloid precursor proteins
27. Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: A chronic oxidative paradigm for testing antioxidant therapies in vivo
28. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress
29. Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice
30. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
31. SW transgenic mouse model for Alzheimer's disease
32. Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology
33. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss
34. Plaque-associated alpha-synuclein (NACP) pathology in aged transgenic mice expressing amyloid precursor protein
35. Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying the mutated human amyloid precursor protein
36. Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease
37. β site APP cleaving enzyme mRNA expression in APP transgenic mice
38. Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy
39. Augmented senile plaque load in aged female β-amyloid precursor protein-transgenic mice
40. Alzheimer's disease in man and transgenic mice: Females at higher risk
41. Quantitative autoradiography of brain binding sites for the vesicular acetylcholine transport blocker 2-(4-phenylpiperidino)cyclohexanol (AH5183)
42. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles
43. Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles
44. 18F]Fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses
45. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease and Parkinson's disease
46. Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol
47. Vesicular acetylcholine transporter density and Alzheimer's disease
48. Regional concentrations of choline and acetylcholine in the rat brain
49. 3H]hemicholinium-3
50. The protease inhibitor, MG132, blocks maturation of the amyloid precursor protein Swedish mutant preventing cleavage by β-secretase
51. A rapid radiochemical method of the determination of choline acetyltransferase
52. Measurement of protein using bicinchoninic acid
53. A new and rapid colorimetric determination of acetylcholinesterase activity
54. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants
55. 42 are generated intracellularly in cultured human neurons and their secretion increases with maturation
56. Topochemical localization of choline acetyltransferase and acetyrcholinesterase in mouse brain
57. Mouse brain distribution of a carbon-11 labeled vesamicol derivative: Presynaptic marker of cholinergic neurons
58. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models
59. 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation
60. Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
61. The levels of soluble versus insoluble brain Aβ distinguish Alzheimer's disease from normal and pathologic aging
62. Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V7171 transgenic mice by a different mechanism than mutant presenilin-1
63. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling
64. Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation
65. Regulation of amyloid precursor protein cleavage
66. Amyloid beta-peptide inhibits high affinity choline uptake and acetylcholine release in rat hippocampal slices
67. Staging of cytoskeletal and β-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease
68. Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice
69. Neurotransmitter enzymes in telencephalon, brain stem and cerebellum during the entire life span of the mouse
70. Age-related alterations in the rodent brain cholinergic system and behavior
71. Presynaptic markers of cholinergic function in the rat brain: Relationship with age and cognitive status
72. Hippocampal neurons and synaptophysin-positive bouton number in aging C57BL/6 mice
73. Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease
74. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function
75. Effects of age and sex on the water maze performance and hippocampal cholinergic fibers in rats
76. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP